Surgical site infection incidence following coronary artery bypass graft surgery was observed across 27,296 procedures within a Medicare population. A facility-level case-control claims analysis demonstrated a significant 25% reduction (P = .04) in suspected surgical site infection at 90 days after coronary artery bypass graft surgery at facilities utilizing a single-patient-use electrocardiography cable and lead wire system.
As the number of surgical procedures performed in the United States continues to rise, so does the burden of surgical site infection (SSI) and the demand for evidence-based interventions. 1 SSIs complicating coronary artery bypass graft (CABG) procedures are significant in terms of morbidity, mortality, and economic influence. 2 Over the past decade, an upward trend in complex sternal infection rates has been observed as patients undergoing CABG present with increasingly complex comorbidities. 3 Patient-related risk factors influencing infection following cardiac surgery have been widely reported in the literature and include older age, obesity, diabetes mellitus, postoperative vasopressive support, transfusion, and prolonged ventilation. 4, 5 The role of critical monitoring devices that come in contact with patients during surgery and throughout the hospital stay and how they may serve as vectors for SSI-causing pathogens remains unclear. Reusable electrocardiography (ECG) lead wires and cables, which are placed on the chest of a patient undergoing CABG in close proximity to sternal incision sites, are often cleaned inadequately between patients and may be a potential vector for SSI transmission. [6] [7] [8] Contaminated reusable ECG lead wires have been previously traced to a vancomycin-resistant enterococci outbreak. 9 Prior research has validated the use of Medicare claims data to estimate facility-level SSI rates following CABG surgery. 10 The objective of this study was to determine the relationship between a single-patient-use ECG cable and lead wire system (Kendall DL; Cardinal Health, Dublin, OH) and SSI risk in Medicare patients undergoing CABG.
METHODS
A retrospective case-control Medicare claims analysis was performed to identify facility-level SSI incidence following CABG procedures performed during a 12-month period between September 9, 2014, and September 28, 2015. Forty-two hospitals using single-patient ECG cable and lead wire systems (single-use facilities) were compared with 274 reusable ECG lead wire facilities (reusable facilities) during the study period.
The Medicare Inpatient and Outpatient Limited Data Set 100% Standard Analytic Files were used for this analysis. Additional facility characteristics were drawn from the 2014 Medicare Provider of Services file.
The 42 single-use facilities were propensity score matched to 274 reusable facilities (1:6 matching) based on specific characteristics chosen to reduce confounders between groups (see Table 1 ). The average Charlson Comorbidity Index score of patients at the time of admission for the CABG index procedure was also included. Medicare fee-for-service patients admitted during the 12-month study period with a ICD-9 procedure code indicating CABG procedure in any position on the admission claim were identified and included 36.10-36.17 and 36.19.
Medicare beneficiary inpatient and outpatient hospital claims from the index CABG admission and within 90 days postprocedure were examined to identify patients with a diagnosis indicating a suspected SSI related to the index procedure. ICD-9 codes used to identify suspected SSI following CABG included 998.50, 998.51, and 998.59.
ANALYSIS
A total of 27,296 CABG procedures were observed during the study period. Single-use facilities performed 4,450 CABG procedures and reusable facilities performed 22,846 procedures. Cumulative SSI incidence observed during the index admission until 90 days post-CABG were then compared between the 2 groups (see Table 2 ). Student t test was used to test for statistical significance, which was defined as P < .05. Statistical analysis was performed using SAS software version 9.4 (SAS Institute Inc, Cary, NC).
RESULTS
Single-use facilities demonstrated an average 14.3% reduction in estimated SSI during the index admission (P = .55), an 18.8% reduction at 30 days (P = .48), a 21% reduction at 60 days (P = .14), and a statistically significant 25% reduction at 90 days post-CABG (P = .04) (Fig 1) .
DISCUSSION
Transitioning to single-patient-use ECG lead wire and cable sets as part of a multimodal infection prevention strategy may significantly reduce SSI incidence. These findings, coupled with increased participation across a variety of advanced alternative payment 
Table 2
Average surgical site infection (SSI) incidence following coronary artery bypass graft (CABG) surgery between facilities using single-patient-use cable and lead wire electrocardiography (ECG) systems versus reusable ECG lead wires
Observation variable
Single-patient-use ECG cable and lead wire system facilities (n = 42)
Reusable ECG lead wire facilities (n = 
CONCLUSIONS
This is the first study to investigate an association between use of single-patient-use ECG lead wire systems and lower CABG SSI rates within a Medicare population. Adoption of such systems may eliminate a source of cross-contamination created by reusable ECG lead wires. Further investigation into the role of ECG lead transmission of SSI causing pathogens before, during, and after surgery is warranted.
